Healthpeak Announces Q3 2026 Results with Raised Full-Year Guidance and Strong Janus Living Growth
Healthpeak (DOC) reported its third-quarter 2026 financial results, highlighted by significant expansion in its senior housing segment through the Janus Living brand. While Adjusted FFO per share saw a slight $0.02 year-over-year decrease to $0.44 due to recent acquisitions, the company raised its full-year FFO guidance to a midpoint of $1.77 per share and increased its total same-store cash NOI guidance. The company demonstrated strong operational momentum in its outpatient medical and lab segments. Janus Living revenue surged 78% year-over-year, driven by $2.1 billion in quarterly acquisition volume. Additionally, the Brookfield joint venture recapitalization provided $1.025 billion in proceeds from the sale of a 49% interest in an outpatient medical portfolio, bolstering Healthpeak's liquidity to $3.8 billion.
Tickers: $DOC
Topics: FFO Guidance Update Medical Real Estate Same-Store Cash NOI Senior Housing